Antinuclear Antibody Test Market Share

Statistics for the 2023 & 2024 Antinuclear Antibody Test market share, created by Mordor Intelligence™ Industry Reports. Antinuclear Antibody Test share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Antinuclear Antibody Test Industry

The antinuclear antibody test market is moderately competitive and consists of several major players. Few of the prominent players currently dominating the market are acquiring the products or other companies to consolidate their global market positions. Launching new products with advanced technologies coupled with recent approvals to diagnose autoimmune diseases is trending in the market. Some companies currently dominating the market are Grifols SA, Abbott Laboratories (Alere Inc.), Abcam plc (BioVision Inc), Antibodies Incorporated, and PerkinElmer Inc.

Antinuclear Antibody Test Market Leaders

  1. Abbott Laboratories (Alere Inc)

  2. Antibodies Incorporated 

  3. Grifols SA

  4. PerkinElmer Inc

  5. Abcam plc (BioVision Inc)

*Disclaimer: Major Players sorted in no particular order

Antinuclear Antibody Test Market.png

Antinuclear Antibody Test Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)